Market revenue in 2023 | USD 4,434.9 million |
Market revenue in 2030 | USD 11,195.2 million |
Growth rate | 14.1% (CAGR from 2023 to 2030) |
Largest segment | Ablation catheters |
Fastest growing segment | Ablation Catheters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostic Catheters, Laboratory Devices, Access Devices, Ablation Catheters |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Abbott Laboratories, Johnson & Johnson, BIOTRONIK, GE Aerospace, Siemens Healthineers AG ADR, MicroPort Scientific Corp, Koninklijke Philips NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to electrophysiology devices market will help companies and investors design strategic landscapes.
Ablation catheters was the largest segment with a revenue share of 44.98% in 2024. Horizon Databook has segmented the U.S. electrophysiology devices market based on diagnostic catheters, laboratory devices, access devices, ablation catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. faces a high prevalence of CVDs, particularly coronary artery disease and HF. These conditions require interventions facilitated by EP devices. According to data published by the American Heart Association in 2018, over 130 million adults in the U.S. are likely to suffer from heart-related diseases by 2035 due to changing lifestyles and the high prevalence of obesity & smoking.
These factors are expected to propel market growth. Furthermore, new product launches address unmet needs within the EP market, such as precise mapping systems, advanced ablation catheters, or implantable devices with improved longevity and performance.
By introducing solutions, companies can capture market share and drive growth in the U.S. EP devices market. For instance, in May 2023, Abbott Laboratories launched the TactiFlex ablation catheter, a sensor-enabled device specifically designed to treat paroxysmal Atrial Fibrillation (AFib) and typical atrial flutter by delivering heat energy to create lesions in the heart tissue.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. electrophysiology devices market, including forecasts for subscribers. This country databook contains high-level insights into U.S. electrophysiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account